Fatigue Reduction in Chronic Kidney Disease (CKD)

Description

In this pilot trial, investigators will pilot test a cognitive behavioral intervention for acceptability and proof of concept for a larger future trial to be submitted for federal funding. This is a one-group design with qualitative and quantitative data collection integrated into the intervention.

Conditions

Chronic Kidney Diseases, Fatigue

Study Overview

Study Details

Study overview

In this pilot trial, investigators will pilot test a cognitive behavioral intervention for acceptability and proof of concept for a larger future trial to be submitted for federal funding. This is a one-group design with qualitative and quantitative data collection integrated into the intervention.

A Pilot Trial of Strategies to Reduce Fatigue for People With Chronic Kidney Disease (CKD)

Fatigue Reduction in Chronic Kidney Disease (CKD)

Condition
Chronic Kidney Diseases
Intervention / Treatment

-

Contacts and Locations

New York

NYU Langone Health, New York, New York, United States, 10016

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Interest in participating in a fatigue study
  • * Age ≥18 years old
  • * Estimated glomerular filtration rate (eGFR) 15-44 mL/min/1.73 m2
  • * Ability and willingness to provide informed consent
  • * Ability to speak English
  • * Ability to walk
  • * Ability to join remote study sessions via WebEx
  • * Current involvement in an activity/exercise program
  • * High likelihood of a kidney transplant within 6 months (assessed via the medical record)
  • * Any safety concerns about increased walking (assessed via the medical record)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

NYU Langone Health,

Daniel Cukor, PhD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

2026-01-31